Chinese tech stocks have been slammed this year, on fears of regulation and uncertainty out of Beijing. James Liu of Clearnomics joins to discuss why he is still bullish on the sector for U.S. investors, despite regulatory headwinds. Plus, Citi’s Global Head of Commodities Research, Ed Morse, joins Worldwide Exchange to discuss his outlook for the sector. And we discuss the performance of biotech and health care stocks this year, and what to expect from the market next year. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
